Skip to main content

Vitamin D in Gambian children with discordant tuberculosis (TB) infection status despite matched TB exposure: a case control study


Using a matched case control design conducted at MRC Gambia in 2015, we measured vitamin D levels in pairs of asymptomatic children with discordant tuberculin skin test status despite the same sleeping proximity to the same adult TB index case. Median ages of groups (infected; 10.0 years, uninfected 8.8 years) were not significantly different (p = 0.13). Mean vitamin D levels were 2.05 ng/mL (95% CI − 0.288 to 4.38) higher in 24 highly TB-exposed uninfected children compared with 24 matched highly TB-exposed infected children (p = 0.08). The findings warrant further investigation in larger studies to understand the implications and significance.

Conclusion: Vitamin D levels were higher in TB-uninfected children compared with TB-infected despite equal high exposure to a TB case.

What is Known:
• Paediatrics TB represents one of the leading causes of child death globally.
• Current literature shows an inconsistent relationship between vitamin D deficiency and increased risk of TB disease however a large Phase 3 trial of vitamin D supplementation in (largely vitamin D deficient) Mongolian children did not find any association with TB infection rates.
What is New:
• This study adds to the literature in a vitamin D sufficient paediatric population whereby children with equal exposure to a household TB case with no evidence of TB infection have higher levels of vitamin D compared with matched children with TB infection.


Vitamin D deficiency has been associated with increased risk of tuberculosis (TB) disease 1, and infection 2; however, the definition of vitamin D deficiency is inconsistent. Host vitamin D receptor (VDR) genetic variants are also associated with risk of TB disease 3. Although vitamin D supplementation has recently been shown not to prevent latent TB infection in Mongolian children 4, vitamin D levels are influenced by genetics, cultural factors, diet, and latitude, making it unclear how these findings may relate to tropical African settings 5. Vitamin D is an immunomodulator with IFN-γ-dependent and IFN-γ and TNF-α-independent host mechanisms to control mycobacteria 6. Vitamin D-dependent antimicrobial peptides are hypothesised to down-regulate host pro-inflammatory responses responsible for lung pathology seen in TB disease 7. A negative tuberculin skin test (TST) or interferon-gamma release assay (IGRA) in an individual with a high risk of Mycobacteria tuberculosis (M.tb) exposure is likely evidence of elimination of the infection via innate immune responses or acquired immune response without T cell priming or memory 8. We hypothesised that vitamin D levels would be higher in highly TB-exposed uninfected Gambian children compared with matched highly TB-exposed infected children. We therefore measured vitamin D levels in stored samples from a 2015 study of pairs of children with discordant latent tuberculosis infection status despite matched exposure to the same household adult tuberculosis index case 9.

Materials and methods

Participant characteristics

As previously reported 9, pairs of asymptomatic children (5–15 years old) with discordant TST status despite equal sleeping proximity in the same building to the same adult index case with smear-positive pulmonary tuberculosis were recruited in the MRC Unit, The Gambia in 2015 (highly TB-exposed uninfected and highly TB-exposed infected children). Briefly, newly identified adult (> 15 years) smear positive TB cases were approached for consent. Children (< 15 years) within a cluster of the index case were consented for screening of TB symptoms and TST evaluation. Highly TB-exposed infected children were those with TST ≥ 10 mm. These children had an in-house IGRA test and were referred for further investigation for symptoms. All participants were screened for TB symptoms at three-monthly intervals for 1 year. Highly TB-exposed uninfected children were defined as TST negative (≤ 5 mm) at study initiation, and at a second TST 3 months after enrolment, despite exposure. All highly TB-exposed infected children were HIV negative, as were the adult TB index cases. Neonatal BCG vaccination in The Gambia is estimated at 98% 10; however, BCG vaccination status for participants was not collected.

Inclusion and exclusion criteria

Smear positive index cases with more than two child contacts (between the ages of 5 and 15 years) were eligible for inclusion. After a valid TST had been placed, read, and recorded, only instances where at least one child had a TST ≥ 10 mm and at least one child had a TST ≤ 5 mm and parental or guardian consent had been given were included.

Children < 5 years were excluded from this study as they were prescribed isoniazid preventative treatment as recommended by the WHO. Children were excluded if they had previously received treatment for TB infection or disease, or if they showed TB symptoms, or had an abnormal chest radiograph.

Sample procedures

Venous blood was collected and serum separated from lithium heparin vacutainer tubes (BD, Oxford, UK). Samples were stored at – 80 °C and shipped on dry ice prior to thawing for analysis.

Vitamin D quantitation

Vitamin D (25(OH)D) in serum was measured using a commercial FDA-approved, validated enzyme immunoassay according to manufacturer instructions (Immunodiagnostic Systems, UK). Vitamin D levels in ng/mL were read from a standard curve. Vitamin D deficiency here is defined as < 10 ng/mL and insufficiency as < 20 ng/mL 11.

Statistical analyses

Shapiro–Wilk test was used to assess data distribution. Paired students’ t test was conducted on the difference in ng/mL 25(OH)D within matched pairs. Wilcoxon’s matched pairs signed rank test was used for age comparisons. McNemars Χ2 test was used for sex comparisons. Analyses were conducted using GraphPad Prism.

Ethical approval

The study was approved by The Gambia Government/MRC Joint Ethics Committee (SCC1405 and SCC1273) and the Imperial College Healthcare Tissue Bank (R13071).


Of the 58 children (29 pairs) recruited to the study, five pairs did not have sufficient stored serum volume for vitamin D measurement for both children in a pair. The remaining 24 pairs (48 children) were included in analyses (Table 1). Median ages did not significantly differ between infected (10.0 years) and uninfected (8.8 years; p = 0.13). There was no significant difference in the proportion of males to females in either group (children = 0.77). Four highly TB-exposed infected children had negative or indeterminate IGRA. No participants developed active TB disease during 12 months of follow-up.

Table 1 Summary of participant characteristics

Mean levels of vitamin D for 24 highly TB-exposed infected children was 18.72 ng/mL; range 10.9–28.6 ng/mL (46.8 nmol/L; range 27–71.5 nmol/L) and 24 highly TB-exposed uninfected children was 20.76 ng/mL; range 12.6–29.7 ng/mL (51.9 nmol/L; range 31.5–74.3 nmol/L), difference 2.05 ng/mL, 95% CI -0.288 to 4.38, p = 0.083; Fig. 1A). While no children included in this study were vitamin D deficient using the threshold of 10 ng/mL, 37.5% of highly TB-exposed uninfected children and 62.5% of highly TB-exposed infected children would be classed as insufficient, being below 20 ng/mL. The difference in proportions of vitamin D insufficient children is not significantly different between the two groups (p = 0.08, Table 1.)

Fig. 1
figure 1

A&B Vitamin D levels among 24 matched pairs (A) and 20 matched (pairs subgroup analysis restricted to 20 pairs of children where the highly TB-exposed infected children had consistent IGRA/TST results at baseline, B) of highly TB-exposed uninfected and infected children. Red dotted line represents vitamin D deficiency threshold of 10 ng/mL; grey dotted line represents vitamin D insufficiency threshold of 20 ng/mL

aWilcoxon’s matched pairs signed rank test, bMcNemars Χ2 test, cpaired Student’s t test.

As was conducted previously 9, a subgroup analysis was performed excluding the four pairs where the highly TB-exposed infected children had discordant IGRA/TST results. This subgroup analysis included 40 children (median ages 9.8 years and 9.1 years for infected and uninfected respectively; p = 0.44). Highly TB-exposed infected children had a mean vitamin D level of 18.08 ng/mL; range 10.9–28.6 ng/mL) (45.2 nmol/L; range 27.3–71.5 nmol/L), whereas the matched highly TB-exposed uninfected children had a mean level of 20.5 ng/mL; range 12.6–29.7 ng/mL (51.3 nmol/L; range 31.5- 74.3 nmol/L), difference 2.46 ng/mL, 95% CI -0.17 to 5.09, p = 0.065, Fig. 1B). All children (infected and uninfected) included in this study were above the threshold of 10 ng/mL (25 nmol/mL) for vitamin D deficiency (Fig. 1B).


Understanding paediatric protective immunity to acquisition of TB infection is vital in order to guide targeting of preventative and adjunctive therapy, vaccine design, and evaluation. Here, we compared vitamin D levels in latently infected children in a TB endemic country in children with a persistently negative TST despite matched household M.tb exposure. We identified a trend towards lower vitamin D levels in children with TB infection than those without evidence of infection; however, this did not reach significance. The trend was consistent in the subgroup analysis restricted to pairs of children where the highly TB-exposed infected children had consistent IGRA/TST results at baseline.

A 2020 household contact study in UK children found a stepwise decline in vitamin D levels from non-infected children to those with TB infection and then children with TB disease, with a significant difference between those with TB infection and TB disease 12. In a large study of 9810 Mongolian school children, Ganmaa et al. report an adjusted risk ratio of 1.23 [95% CI, 1.08–1.40], p = 0.002 for vitamin D deficiency, defined as < 10 ng/mL, and TB infection as determined by the QuantiFERON-TB (QFT) Gold assay 2. A subsequent phase 3 randomised controlled study in over 8,800 Mongolian children found that vitamin D oral supplementation over 3 years was not associated with any difference in QFT positivity, despite a mean increase of over 20 ng/mL vitamin D in the supplemented group 4.

A meta-analysis of 3,544 (mainly adult) participants from 13 countries included in prospective trials investigating vitamin D and TB risk found a median vitamin D level of 26 ng/mL (65.0 nmol/L; IQR 19.5–33.4 ng/mL) and a dose-dependent relationship between deficiency of vitamin D (< 10 ng/mL) and increased risk of incident TB, a finding which was significantly exacerbated by HIV 1. Another meta-analysis restricted to children < 18 years found that vitamin D deficiency was associated with TB with a pooled OR of 1.78 (95% CI 1.30–2.44, p < 0.05); however, the definition of vitamin D deficiency varied between < 30 ng/mL, < 20 ng/mL, and < 10 ng/mL in the studies included 13. The applicability of these findings to the Gambian population being studied here is not clear. While no Gambian children studied here would be classed as deficient using the 10 ng/mL (25 nmol/L) threshold for vitamin D deficiency, between 37.5% (highly TB-exposed uninfected) and 62.5% (highly TB-exposed infected) would be classed as insufficient by the thresholds used here. The Mongolian phase 3 study found that 31.8% of children had vitamin D levels below 10 ng/mL 4, and between 24% (of uninfected children) and 63% (of children with TB disease) included in the UK study were deemed vitamin D deficient using the same threshold 12.

While the trend between elevated vitamin D and absence of TB infection despite high TB-exposure reported here is consistent with results from existing literature 1, 12, a study in Gambian adults reporting higher serum vitamin D levels in adults with TB disease compared to household contacts 5 points towards variation in associations even within the same country.

Strengths of this study include the careful exposure-matched study design, comparing experimental data on samples from school-age children with TB infection to those who remain persistently uninfected despite defined household contact with an adult with smear-positive pulmonary tuberculosis. The original study was not powered to detect differences in vitamin D levels. Therefore, the small sample size of pairs of children from whom sufficient sample was available for this exploratory analysis is a limitation. IGRA status was available at baseline for the highly TB-exposed infected children but was not available for the highly TB-exposed uninfected children. Potentially confounding factors that may affect vitamin D levels (such as diet) are likely to be equally distributed within pairs living in the same household compound; therefore, the magnitude of vitamin D differences may be small.

Our data from this largely vitamin D-sufficient group of children with household tuberculosis exposure in a tropical African climate contribute to the body of evidence that higher vitamin D levels may be linked to lower risk of acquisition of TB infection. Larger studies utilising similar epidemiological designs in high TB-prevalence countries with distinct climates are required to further elucidate the connection between vitamin D levels and immunity against tuberculosis infection.

Availability of data and material

All data will be made available.

Code availability

Not applicable.



Interferon-gamma release assay

M.tb :

Mycobacteria tuberculosis




Tuberculin skin test


Vitamin D receptor


  1. Aibana O et al (2019) Vitamin D status and risk of incident tuberculosis disease: a nested case-control study, systematic review, and individual-participant data meta-analysis. PLOS Med 16:e1002907

  2. Ganmaa D et al (2019) Prevalence and determinants of QuantiFERON-diagnosed tuberculosis infection in 9810 Mongolian schoolchildren. Clin Infect Dis 69:813–819

    Article  Google Scholar 

  3. Xu X, Shen M (2019) Associations between vitamin D receptor genetic variants and tuberculosis: a meta-analysis. Innate Immun 25:305–313

    CAS  Article  Google Scholar 

  4. Ganmaa D et al (2020) Vitamin D supplements for prevention of tuberculosis infection and disease. N Engl J Med 383:359–368

    CAS  Article  Google Scholar 

  5. Owolabi O et al (2016) Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults. Tuberculosis 98:86–91

    CAS  Article  Google Scholar 

  6. Bloom BR, Modlin RL (2016) Mechanisms of defense against intracellular pathogens mediated by human macrophages. Microbiol Spectr 4:1–11

    CAS  Article  Google Scholar 

  7. Teles RMB et al (2013) Type I interferon suppresses type II interferon–triggered human anti-mycobacterial responses. Science 80(339):1448–1454

  8. Koeken VACM, Verrall AJ, Netea MG, Hill PC, van Crevel R (2019) Trained innate immunity and resistance to Mycobacterium tuberculosis infection. Clin Microbiol Infect 25:1468–1472

    CAS  Article  Google Scholar 

  9. Basu Roy R et al (2020) Protection against mycobacterial infection: a case-control study of mycobacterial immune responses in pairs of Gambian children with discordant infection status despite matched TB exposure. EBioMedicine 3:102891

  10. World Health Organization U (2019) The Gambia: WHO and UNICEF estimates ofimmunization coverage: 2019 revision. Available at:

  11. Esposito S, Lelii M (2015) Vitamin D and respiratory tract infections in childhood. BMC Infect Dis 15:1–10

    Article  Google Scholar 

  12. McArdle AJ et al (2020) Vitamin D deficiency is associated with tuberculosis disease in British children. Int J Tuberc Lung Dis 24:782–788

    CAS  Article  Google Scholar 

  13. Gou X, Pan L, Tang F, Gao H, Xiao D (2018) The association between vitamin D status and tuberculosis in children: a meta-analysis. Medicine (United States) 97

Download references


The authors would like to thank the children and families in the Gambia who participated in this study and the Childhood TB team at MRC Unit The Gambia at LSHTM. Thanks to Stephen Nash for his statistical advice and guidance.


The vitamin D quantification was funded by an Academy of Medical Sciences Starter Grant for Clinical Lecturers to RBR (SGL019\1045). RBR is funded by an NIHR Academic Clinical Lectureship (CL-2018–20-001). The case control study in The Gambia was funded by a Clinical Research Training Fellowship to RBR that was jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and was also part of the EDCTP2 programme supported by the European Union (MR/K023446/1). The case control study was also enabled by BK’s MRC Program Grant (MR/K007602/1, MR/K011944/1, MC_UP_A900/1122).

Author information

Authors and Affiliations



LS carried out laboratory work, analysed the data, and wrote the manuscript. BS, MS, UE, and AKS recruited participants and collected samples. BK and RBR conceptualised the study. All authors reviewed and added to the manuscript.

Corresponding author

Correspondence to Lisa Stockdale.

Ethics declarations

Ethics approval

The study was approved by The Gambia Government/MRC Joint Ethics Committee (SCC1405 and SCC1273) and the Imperial College Healthcare Tissue Bank (R13071).

Consent to participate

All participants consented to participate in the study.

Consent for publication

All participants consented to publication of analyses.

Conflict of interest

The authors declare no competing interests.

Additional information

Communicated by Nicole Ritz

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stockdale, L., Sambou, B., Sissoko, M. et al. Vitamin D in Gambian children with discordant tuberculosis (TB) infection status despite matched TB exposure: a case control study. Eur J Pediatr 181, 1263–1267 (2022).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Tuberculosis
  • Vitamin D
  • The Gambia
  • TB
  • Paediatric
  • Case control